CLINICAL AND IMMUNOLOGICAL EFFICASY OF MODERN MUCOSAL VACCINE IN CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS
https://doi.org/10.15690/vsp.v11i5.437
Abstract
A 5-year clinical observation of 40 children with frequent respiratory infections and otorhinolaryngologic disorders at the age of from 6 months to 5 years was performed in order to assess clinical and immunological efficacy of modern mucosal vaccine. The tested medicine was shown to significantly decrease the frequency of respiratory infections and necessity of antibacterial treatment and to raise the level of serum IgA. The after-effect of the drug lasted for 1–2 years.
References
1. Ермилова Н. В., Радциг Е. Ю., Богомильский М. Р. Профилак тика ОРВИ в организованных детских коллективах: способы и эффективность. Вопросы современной педиатрии. 2012; 11 (1): 98–102.
2. Медицинские стандарты (протоколы) диагностики и лечения больных с аллергическими заболеваниями и нарушениями иммунной системы. Под ред. Р. М. Хаитова. М.: РААКИ. 2001. 120 с.
3. Климов В. В., Кологривова Е. Н., Черевко Н. А. и др. Клиническая иммунология и аллергология. Под ред. В. В. Климова. Томск: Печатная мануфактура. 2008. 212 с.
4. Clot J. Pharmacology of Ribosomal Immunotherapy. Adv. Ribosom. Immunother. 1997; 54: 33–36.
5. Portales P., Clot J. Immunostimulants revisited: focus on the pharmacology of Ribomunyl. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 2006; 20 (2): 81–84.
6. Herberhold S., Coch C., Zillinger T. et al. Delivery with polycations extends the immunostimulant Ribomunyl into a potent antiviral Tolllike receptor 7/8 agonist. Antivir. Ther. 2011; 16 (5): 751–758.
7. Bousquet J., Oliveri D. Role of Ribomunyl in the prevention of recurrent respiratory tract infections: overview of clinical results. Treatments in Respiratory Medicine. 2006; 5 (5): 317–324.
8. Jankowski A., Lewandowicz-Uszynska A., Polanska B. et al. Kliniczna skutecznosc ribomunylu na podstawie doswiadczen wlasnych. Clinical efficiency of ribomunyl in own experience. Przeglad Pediatryczny. 2006; 36 (4): 263–267.
Review
For citations:
Klimov V.V. CLINICAL AND IMMUNOLOGICAL EFFICASY OF MODERN MUCOSAL VACCINE IN CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS. Current Pediatrics. 2012;11(5):109-112. (In Russ.) https://doi.org/10.15690/vsp.v11i5.437